Cover Image

Treatment of chronic myeloid leukemia when imatinib fails

Introduction: Imatinib failure represents a major clinical challenge in the management of chronic myeloid leukemia. Areas covered: Definition of failure, its causes, the various approaches to the treatment of imatinib failure such as imatinib dose escalation, second-generation tyrosine kinase inhibi...

Full description

Saved in:
Bibliographic Details
Main Authors: Hehlmann, Rüdiger (Author) , Jung-Munkwitz, Susanne (Author) , Saußele, Susanne (Author)
Format: Article (Journal)
Language:English
Published: 13 Jan 2011
In: Expert opinion on pharmacotherapy
Year: 2011, Volume: 12, Issue: 2, Pages: 269-283
ISSN:1744-7666
DOI:10.1517/14656566.2011.533169
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1517/14656566.2011.533169
Get full text
Author Notes:Rüdiger Hehlmann, Susanne Jung-Munkwitz, Susanne Saußele

MARC

LEADER 00000caa a2200000 c 4500
001 1817726056
003 DE-627
005 20230710113200.0
007 cr uuu---uuuuu
008 220928s2011 xx |||||o 00| ||eng c
024 7 |a 10.1517/14656566.2011.533169  |2 doi 
035 |a (DE-627)1817726056 
035 |a (DE-599)KXP1817726056 
035 |a (OCoLC)1389782369 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hehlmann, Rüdiger  |d 1941-  |e VerfasserIn  |0 (DE-588)1037003489  |0 (DE-627)751737879  |0 (DE-576)390939463  |4 aut 
245 1 0 |a Treatment of chronic myeloid leukemia when imatinib fails  |c Rüdiger Hehlmann, Susanne Jung-Munkwitz, Susanne Saußele 
264 1 |c 13 Jan 2011 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.09.2022 
520 |a Introduction: Imatinib failure represents a major clinical challenge in the management of chronic myeloid leukemia. Areas covered: Definition of failure, its causes, the various approaches to the treatment of imatinib failure such as imatinib dose escalation, second-generation tyrosine kinase inhibitors and stem cell transplantation, and monitoring of residual disease are covered in this review. Selected investigational agents and the management of blast crisis are also reviewed. After reading the review the reader will understand how to manage imatinib failure. Expert opinion: Imatinib failure can be managed in most cases by a careful appraisal of its causes and a rational selection of treatment options. 
650 4 |a chronic myeloid leukemia 
650 4 |a clonal evolution 
650 4 |a dasatinib 
650 4 |a imatinib failure 
650 4 |a nilotinib 
650 4 |a resistance mutants 
650 4 |a transplantation 
700 1 |a Jung-Munkwitz, Susanne  |d 1972-  |e VerfasserIn  |0 (DE-588)129818496  |0 (DE-627)481322361  |0 (DE-576)297851373  |4 aut 
700 1 |a Saußele, Susanne  |d 1968-  |e VerfasserIn  |0 (DE-588)115839860  |0 (DE-627)69162786X  |0 (DE-576)29010694X  |4 aut 
773 0 8 |i Enthalten in  |t Expert opinion on pharmacotherapy  |d Abingdon, Oxon : Routledge, Taylor & Francis, 1999  |g 12(2011), 2 vom: Jan., Seite 269-283  |h Online-Ressource  |w (DE-627)324741901  |w (DE-600)2030119-4  |w (DE-576)302969330  |x 1744-7666  |7 nnas  |a Treatment of chronic myeloid leukemia when imatinib fails 
773 1 8 |g volume:12  |g year:2011  |g number:2  |g month:01  |g pages:269-283  |g extent:15  |a Treatment of chronic myeloid leukemia when imatinib fails 
856 4 0 |u https://doi.org/10.1517/14656566.2011.533169  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220928 
993 |a Article 
994 |a 2011 
998 |g 115839860  |a Saußele, Susanne  |m 115839860:Saußele, Susanne  |d 60000  |d 61200  |e 60000PS115839860  |e 61200PS115839860  |k 0/60000/  |k 1/60000/61200/  |p 3  |y j 
998 |g 129818496  |a Jung-Munkwitz, Susanne  |m 129818496:Jung-Munkwitz, Susanne  |d 60000  |d 61200  |e 60000PJ129818496  |e 61200PJ129818496  |k 0/60000/  |k 1/60000/61200/  |p 2 
998 |g 1037003489  |a Hehlmann, Rüdiger  |m 1037003489:Hehlmann, Rüdiger  |d 60000  |d 61200  |d 60000  |e 60000PH1037003489  |e 61200PH1037003489  |e 60000PH1037003489  |k 0/60000/  |k 1/60000/61200/  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1817726056  |e 4193049744 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"pubHistory":["1.1999/2000 -"],"titleAlt":[{"title":"EOP"}],"disp":"Treatment of chronic myeloid leukemia when imatinib failsExpert opinion on pharmacotherapy","title":[{"subtitle":"EOP","title_sort":"Expert opinion on pharmacotherapy","title":"Expert opinion on pharmacotherapy"}],"id":{"issn":["1744-7666"],"zdb":["2030119-4"],"eki":["324741901"]},"recId":"324741901","part":{"extent":"15","year":"2011","pages":"269-283","text":"12(2011), 2 vom: Jan., Seite 269-283","issue":"2","volume":"12"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"Abingdon, Oxon ; London [u.a.]","dateIssuedKey":"1999","dateIssuedDisp":"1999-","publisher":"Routledge, Taylor & Francis ; Informa Healthcare"}]}],"physDesc":[{"extent":"15 S."}],"person":[{"family":"Hehlmann","roleDisplay":"VerfasserIn","given":"Rüdiger","role":"aut","display":"Hehlmann, Rüdiger"},{"family":"Jung-Munkwitz","roleDisplay":"VerfasserIn","role":"aut","display":"Jung-Munkwitz, Susanne","given":"Susanne"},{"display":"Saußele, Susanne","role":"aut","given":"Susanne","roleDisplay":"VerfasserIn","family":"Saußele"}],"name":{"displayForm":["Rüdiger Hehlmann, Susanne Jung-Munkwitz, Susanne Saußele"]},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"13 Jan 2011"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 28.09.2022"],"recId":"1817726056","id":{"doi":["10.1517/14656566.2011.533169"],"eki":["1817726056"]},"title":[{"title":"Treatment of chronic myeloid leukemia when imatinib fails","title_sort":"Treatment of chronic myeloid leukemia when imatinib fails"}]} 
SRT |a HEHLMANNRUTREATMENTO1320 

Similar Items